Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
D000368:Aged; D001344:Autopsy; D001479:Basal Ganglia / Q000378:metabolism; D001565:Benzoates / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism* / Q000473:pathology; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D004660:Encephalitis / Q000150:complications; D005260:Female; D005917:Globus Pallidus / Q000378:metabolism* / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism* / Q000473:pathology; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000378:metabolism; D009128:Muscle Spasticity / Q000473:pathology; D009410:Nerve Degeneration; D010300:Parkinson Disease / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D013378:Substantia Nigra / Q000378:metabolism* / Q000473:pathology; D014202:Tremor / Q000378:metabolism
D001565:Benzoates; D004295:Dihydroxyphenylalanine; D004298:Dopamine